학술논문

First in human phase 1/2a study evaluating the safety and efficacy of the Akt activator, IPL344 in ALS (NCT03652805, NCT03755167).
Document Type
Journal
Source
MUSCLE & NERVE; NOV 2022, 66 pS47-pS48, 2p. Supplement: 2
Subject
Language
English
ISSN
10974598